Skip to content
MedCompare

Sorafenib

Also known as Nexavar (us), Soranib (india)

Cancer & Oncology
Save $2,520/mo
89× cheaper

Sorafenib is used to treat advanced renal cell carcinoma (RCC; a type of cancer that begins in the kidneys).

United States
$2,549
per month
India
$29
per month
You save
$2,520
99% cheaper in India
3.7K US scripts/yr$9.3M potential annual savings$9.4M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC21H16ClF3N4O3

SMILES: CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F

Compare the price
US price$2,549per month
India price$29per month
You save$2,52099% less

Based on 30 units per month. US $84.96 vs India $0.96 per unit.

Total over 1 periodSave $2,520$2,549 → $29
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$15,120
Estimated travel cost
− $2,300
Net savings after travel
$12,820

Even after travel, you could come out ahead by about $12,820.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Sorafenib is filled about 3.7K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$9.4M
If sourced from India
$106.2K
Potential annual savings
$9.3M
−99%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.